Millicent Pharma - M&A Summary, Ownership, and Business Overview

Life ScienceCompany

Millicent Pharma M&A Summary

Millicent Pharma has acquired 1 company of its own, including 1 in the last 5 years.

Millicent Pharma’s largest acquisition to date was in 2020, when it acquired AMAG Pharmaceuticals - INTRAROSA Rights for $125M. Millicent Pharma has acquired in 1 US state. The Company’s most targeted sectors include life science (100%).

Millicent Pharma Ownership

Who owns Millicent Pharma?

Millicent Pharma is owned by Bourne Partners Strategic Capital and The Carlyle Group. It was acquired on May 21, 2018.

Is Millicent Pharma PE-backed?

Yes. Millicent Pharma is owned by private equity investors Bourne Partners Strategic Capital and The Carlyle Group.

Millicent Pharma Business Overview

Where is Millicent Pharma headquartered?

Millicent Pharma is headquartered in Dundalk, Ireland.

What sector is Millicent Pharma in?

Millicent Pharma is a life science company.

When was Millicent Pharma founded?

Millicent Pharma was founded in 2018.

M&A Summary

  • M&A Total Activity1
    • M&A Buy Activity1
  • Total Sectors Invested 1
  • Total Countries Invested 1
  • M&A Buy/Sell Connections 1

Millicent Pharma

Millicent Pharma Ltd.

Block 4, Floor 2, Quayside Business Park, Mills Street,
Dundalk, A91 KA9R
Ireland,

Millicent Pharma is a pharmaceutical company that is focused on improving patient lives and outcomes and seeks to acquire, develop, manufacture, and commercialize pharmaceutical products globally. Millicent Pharma was founded in 2018 and is based in Dundalk, Ireland.


M&A Summary

Buy vs Sell

Year ≤ '19 '20 '21 '22 '23 '24 T
Buy (0.2/yr) # - 1 - - - - 1
vol $125M $125M
Sell (0.0/yr) # - - - - - - 0
  1

Most Recent M&A

Company Date Value Type
AMAG Pharmaceuticals, Inc. - INTRAROSA Rights 2020-05-21 125M USD Divestiture
Waltham, Massachusetts · www.us.intrarosa.com
View All >>

M&A by Sector

Sector Buy # Value Sell # Value
Life Science 1 (100%) 125M (100%) - -
Total 1 $125M - -

By Geo

State/Country Buy Value Sell Value
United States 1 125M - -
  Massachusetts 1 125M - -
Total 1 $125M - -

Deal Values

buy # Total
$100M to $1B 1 $125M
TOTAL $125M
Largest AMAG Pharmaceuticals, Inc. - INTRAROSA Rights
$125M (2020-05-21)

M&A Connections

Deals
Acquired from
Strategic(s)
100%
1 (100%)

 Subscribe to unlock this and 206,067
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.6K Private Equity Firms
  • 198K M&A Transactions
  • 201K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 79K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.

Related Lists for Millicent Pharma

Life Science Companies , Ireland Companies